L3VLUP
← Every manager
Free · no sign-up · Q2 2026

Which funds own GSK

Gsk plc in the Q2 2026 filings. At least 7 of the 91 current managers on file reported a position, worth $7.1bn between them. It is among the largest positions of fewer than a fifth of the current managers on file. The quarter went the other way: 7 managers trimmed or sold out against 2 buying.

Managers holding
7
at least, of 91 current
Combined value
$7.1bn
as reported
Opened
2
new this quarter
Added to
0
already held
Trimmed or sold out
7
2 sold out entirely

Only each manager’s largest 200 positions are listed here, so a smaller holder may be missing.

Managers reporting a position

Largest first. Weight is the share of that manager’s whole reported book, which is the number worth quoting: $400m is a rounding error in one book and a defining bet in another.

ManagerValueWeightSharesChange on the quarterAction
Fidelity (FMR LLC)
Long-only · $2304bn book
$3.4bn0.1%64,961,641-$329m-2,700,005Trimmed
Dodge & Cox
Activist · $191bn book
$2.5bn1.3%48,197,514-$711m-10,465,460Trimmed
Wellington Management Group LLP
Long-only · $580bn book
$597m0.1%11,396,249-$49m-321,364Trimmed
Acadian Asset Management LLC
Quantitative · $84.2bn book
$349m0.4%6,660,434-$302m-5,136,651Trimmed
Point72 Asset Management LP
Multi-strategy · $90.7bn book
$139m0.2%2,652,881opened2,652,881New
Bridgewater Associates LP
Macro · $24.4bn book
$26m0.1%504,171-$12m-194,495Trimmed
Quantbot Technologies LP
Quantitative · $2.5bn book
$6.7m0.3%128,286opened128,286New

Sold out of this quarter

Valued at what the position was worth in the previous filing, because by this one it is gone.

Ownership through time

At least 11 of the 95 managers whose filings are on file listed GSK in Q2 2026, against 1 in Q2 2022. 2 managers more than in Q1 2026: 3 started positions; 1 sold out, by its own filing.

Each manager’s largest 500 positions a quarter are read, so a small holding in a very large book can be missing, and a manager is counted as leaving only where its own filing shows it.

Managers on file listing it
0918Q2 2022: 1Q3 2022: 18Q4 2022: 18Q1 2023: 1323Q2 2023: 13Q3 2023: 16Q4 2023: 13Q1 2024: 1324Q2 2024: 10Q3 2024: 10Q4 2024: 13Q1 2025: 1125Q2 2025: 10Q3 2025: 11Q4 2025: 11Q1 2026: 926Q2 2026: 11
  • Q2 2022: 1
  • Q3 2022: 18
  • Q4 2022: 18
  • Q1 2023: 13
  • Q2 2023: 13
  • Q3 2023: 16
  • Q4 2023: 13
  • Q1 2024: 13
  • Q2 2024: 10
  • Q3 2024: 10
  • Q4 2024: 13
  • Q1 2025: 11
  • Q2 2025: 10
  • Q3 2025: 11
  • Q4 2025: 11
  • Q1 2026: 9
  • Q2 2026: 11
Their combined reported value
$0$5bn$9bnQ2 2022: $19mQ3 2022: $3.9bnQ4 2022: $4.9bnQ1 2023: $4.4bn23Q2 2023: $4.3bnQ3 2023: $4.5bnQ4 2023: $4.5bnQ1 2024: $5.3bn24Q2 2024: $4.6bnQ3 2024: $4.9bnQ4 2024: $4.9bnQ1 2025: $6.3bn25Q2 2025: $6.2bnQ3 2025: $7.5bnQ4 2025: $8.8bnQ1 2026: $9.1bn26Q2 2026: $7.5bn
  • Q2 2022: $19m
  • Q3 2022: $3.9bn
  • Q4 2022: $4.9bn
  • Q1 2023: $4.4bn
  • Q2 2023: $4.3bn
  • Q3 2023: $4.5bn
  • Q4 2023: $4.5bn
  • Q1 2024: $5.3bn
  • Q2 2024: $4.6bn
  • Q3 2024: $4.9bn
  • Q4 2024: $4.9bn
  • Q1 2025: $6.3bn
  • Q2 2025: $6.2bn
  • Q3 2025: $7.5bn
  • Q4 2025: $8.8bn
  • Q1 2026: $9.1bn
  • Q2 2026: $7.5bn

Between the quarter ends of Q1 2026 and Q2 2026. Each change in shares is valued at the Q2 2026 price, so the price’s own move is left out; a 13F shows the two quarter ends, not when in between anything was bought or sold.

Largest increases, by shares

Largest decreases, by shares

Left it

ManagerValue over timeFirst listedLargestQ2 2026
Fidelity (FMR LLC)Q3 2022$3.7bn$3.4bn
Dodge & CoxQ3 2022$3.4bn$2.5bn
Wellington Management Group LLPQ3 2025$647m$597m
T. Rowe Price Associates IncQ3 2022$492m$363m
Acadian Asset Management LLCQ3 2022$651m$349m
Point72 Asset Management LPQ3 2022$227m$139m
Arrowstreet Capital LPQ3 2022$494m$86m
Bridgewater Associates LPQ4 2022$76m$26m
Walleye Capital LLCQ1 2026$21m$21m
Schonfeld Strategic Advisors LLCQ3 2022$76m$10m
Quantbot Technologies LPQ3 2022$8.6m$6.7m
Holocene Advisors LPQ1 2023$398mlast listed Q1 2026
Renaissance Technologies LLCQ3 2022$275mlast listed Q4 2025
Two Sigma Investments LPQ3 2022$210mlast listed Q4 2024
Millennium Management LLCQ3 2022$156mlast listed Q3 2023
Two Sigma Advisers LPQ3 2022$133mlast listed Q4 2022
Capital Research Global InvestorsQ3 2022$77mlast listed Q3 2025
Voloridge Investment Management LLCQ3 2022$73mlast listed Q4 2024
Balyasny Asset Management LLCQ3 2022$73mlast listed Q3 2025
Marshall Wace LLPQ2 2022$64mlast listed Q1 2023
Jane Street Group LLCQ4 2022$63mlast listed Q4 2022

What GSK is worth

Knowing who owns it is half the question. The other half is what it is worth against the companies it trades beside, which is the one an interviewer will follow up with.

Build the comp set around GSK →

How much of the picture this is

A Form 13F reports US-listed long equity and nothing else: no shorts, no bonds, no cash and no non-US listings. It arrives forty-five days after the quarter ends, so a manager who sold in July still shows the position in a filing published in August. This page reads the managers on file here rather than every filer in the market, and each manager’s largest positions rather than the whole table, so a small position in a very large book may not appear. Say “their last filing showed” rather than “they own”, and the distinction will do you credit.

What to do with a name the funds are buying

Knowing who owns something is the start of a pitch, not the pitch. The next questions are what it is worth and why they were buying.

Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More

The holdings, every quarter, and the week between

One email a week on what moved in the market and what it means for the people interviewing into it, with the 13F changes the quarter they are filed.

One email a week, free, and you can leave at any point.